|
Demographic reporting
|
| Reported sampled age |
84 (97%) |
| Adults (> 18 years) |
76 (90%) |
| Children only |
5 (6%) |
| Young adults (18–24 years) only |
2 (2%) |
| Older adults (>65 years) |
1 (1%) |
| Reported sex and/or gender |
83 (95%) |
| Reported racialization and/or ethnicity |
39 (45%) |
| Reported socioeconomic status |
30 (34%) |
| Reported education level |
22 (25%) |
| Reported sexual orientation |
2 (2%) |
|
Description of included participants
|
| People prescribed medical cannabis |
11 (13%) |
| People who use drugs |
11 (13%) |
| People who use cannabis non-medically |
4 (5%) |
| People prescribed opioid agonist therapy |
4 (5%) |
| People living with: |
| Cancer |
8 (9%) |
| Epilepsy, Dravet Syndrome, or CDKL5 deficiency disorder |
8 (9%) |
| Acute and chronic pain |
8 (9%) |
| Neuromuscular and movement disorders |
6 (7%) |
| HIV/AIDS |
3 (3%) |
| COPD |
3 (3%) |
| Inflammatory and autoimmune disease |
2 (2%) |
| Acute infection |
1 (1%) |
| Varicose veins |
1 (1%) |
| Sleepwalking |
1 (1%) |
| Gambling addiction |
1 (1%) |
| Chronic disease risk factors |
1 (1%) |
| Cannabis use disorder |
1 (1%) |
| Healthy volunteers |
7 (8%) |
| Bereaved family members or sudden death in children |
3 (3%) |
| Military veterans |
2 (2%) |
| Cannabis dispensary staff |
1 (1%) |
